Angiotensin receptor blockers and cancer – Relationship dismissed by VALUE data while waiting for EMA and FDA reports

Author： Kjeldsen Sverre E.   Hedner Thomas   Oparil Suzanne   Narkiewicz Krzysztof  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.19, Iss.5, 2010-10, pp. : 271-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prescription Data Related to the Use of Calcium Channel Blockers, ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) in Combination Identify Savings Opportunities

By Carugo Stefano  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 21-26

Adis International

Access to resources Recommend Favorite

2010 Position Paper of the Italian Society of Hypertension (SIIA): Angiotensin Receptor Blockers and Risk of Cancer

By Volpe Massimo   Morganti Alberto  

High Blood Pressure & Cardiovascular Prevention, Vol. 18, Iss. 1, 2011-03 ,pp. : 37-40

Adis International

Access to resources Recommend Favorite

Angiotensin Receptor Blockers in Hypertension and Cardiovascular Diseases

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 4, Iss. 1, 2006-01 ,pp. : 67-73

Bentham Science Publishers

Access to resources Recommend Favorite

Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers

By  

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Angiotensin Receptor Blockers and Target-Organ Protection Beyond Blood Pressure Control

By Riccardo Sarzani   Paolo Dessì-Fulgheri   Alessandro Rappelli  

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 2, 2004-01 ,pp. : 65-73

Adis International

Access to resources Recommend Favorite